The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
Natural immunity to breast and prostate cancers is predicted by a novel, saturated
ordered mutation model fitted to USA (SEER) incidence data, a prediction consistent with
the latest ideas in immunosurveillance. For example, the prevalence of natural immunity to
breast cancer in the white female risk population is predicted to be 76.5%; this immunity
may be genetic and, therefore, inherited. The modeling also predicts that 6.9% of White
Females are...
Currently displaying 1 –
5 of
5